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Summary Ecthyma gangrenosum (EG) manifests as a skin lesion and is commonly associated
with Pseudomonas aeruginosa septicemia in immunocompromised patients. Other viral, fungal
and bacterial agents can also cause EG. The first clinical observation is grouped vesicles with
surrounding erythema. Within a few days, they evolve into a gangrenous ulcer with a black/gray
eschar surrounded by an erythematous halo. Herein, we present a patient with chronic obstruc-
tive pulmonary disease who developed EG-like lesions due to methicillin-resistant Staphylococcus
aureus infection while he was in the intensive care unit.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Ecthyma gangrenosum (EG), which first appears at the skin
and mucosa, is a necrotizing vasculitis commonly caused by
Pseudomonas aeruginosa. Malnutrition, severe neoplasia or
hematological diseases, resulting in immunosuppression, are
non-bacterial causes of EG.1 The first clinical observation is
grouped vesicles with surrounding erythema; within a few
days, they form a gangrenous ulcer with a black/gray eschar
surrounded by an erythematous halo.2 In this report, we
present a patient with chronic obstructive pulmonary disease* Corresponding author. Gu¨lhane Military Medical Academy Hay-
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doi:10.1016/j.ijid.2008.09.011(COPD) who developed EG-like lesions due to methicillin-
resistant Staphylococcus aureus (MRSA) infection while he
was in the intensive care unit (ICU). To the best of our
knowledge, this is the first case in the literature in which
MRSA is reported to be the underlying cause of such lesions.
Case report
A 69-year-old male, diagnosed with COPD 20 years previously,
was admitted to the emergency department for acute dys-
pnea and confusion possibly due to COPD. His vital signs were
as follows: blood pressure 170/95 mmHg; heart rate 98 bpm;
body temperature 37.5 8C; and respiratory rate 32/min. He
was disoriented and cyanotic. Upon auscultation, respiratory
sounds were decreased; rales and wheezing could be
detected. Chest radiographs revealed an infiltration at the
right middle lobe. Arterial blood gas values were: pO2 68Published by Elsevier Ltd. All rights reserved.
Figure 2 Several similar lesions on the dorsum of the hand and
the fingers with edema.
Figure 1 Dark purple macular lesions on the inner side of the
foot.
e174 H. S¸en et al.mmHg; pCO2 80 mmHg; pH 7.31. Laboratory tests yielded:
white blood cell (WBC) count 18.7  109/l; hemoglobin (Hb)
16.9 mg/dl; blood urea nitrogen 57 mg/dl; platelet (Plt) 205
000/ml; albumin 2.8 g/dl; C-reactive protein level 68 mg/l;
erythrocyte sedimentation rate 93 mm/hour. Other labora-
tory values were normal. Oxygen (5 l/min) was administered
with a nasal cannula. Nebulized ipratropium-bromide/salbu-
tamol and parenteral theophylline were given. As the patient
did not improve, he was intubated and transferred to the ICU.
The COPD was treated with N-acetylcysteine and methyl-
prednisolone, in addition to the above-mentioned drugs. A
combination of tazocin 3  4.5 g/day and amikacin 1 g/day
was initiated for concomitant pneumonia.
On the 5th day in the ICU, the patient was extubated and
his vital signs normalized. Laboratory values were normal
(WBC count 9.6  109/l; Hb 9.1 g/dl; Plt 195 000/ml). On
the 7th day, antibiotics were stopped. On the 12th day, the
patient had an elevated pCO2 and he was again intubated
for mechanical ventilation. His WBC count was 13.3  109/l
and Plt was 202 000/ml, and he had a temperature of
38.2 8C. On the 15th day, mottled skin lesions on the upper
and lower extremities were detected. After a few days, the
macular lesions progressed to huge bullae, 3 cm in diameter
(Figures 1 and 2). The lesions were erythematous and
edematous around the necrotic center, consistent with
EG. Cultures taken both from the lesions and from the
blood were positive for MRSA. Treatment was administered
with ampicillin/sulbactam 4  1 g/day, meropenem
3  1 g/day, and teicoplanin 2  400 mg/day for the firstthree days and then reduced to 400 mg/day. On the 18th
day, his arterial blood pressure decreased and a positive
inotropic agent was started. The skin lesions were observed
to become necrotic. Laboratory values were WBC count
6200/ml and Hb 7.8 g/dl. The patient then developed
hypothermia (34.3—35.4 8C). On the 28th day of his stay
in the ICU, the patient died from septic shock.
Discussion
EG, which can be seen in forms ranging frommacula lesions to
necrotic ulcers, is commonly observed in patients with malig-
nancy or neutropenia. There are two main types, with bac-
teremia and without bacteremia, according to its
pathogenesis. Skin lesions of the bacteremic type occur by
hematological spread and blood cultures are positive. In the
nonbacteremic form, lesions occur on the skin where organ-
isms are inoculated. The latter has a better prognosis than
the bacteremic form.3 On average, 50% of lesions are located
in the gluteal and perineal regions, 30% on the extremities,
and 12% on the face and body.4 In our patient, lesions first
appeared on the extremities.
After invasion of the tunica adventitia of the post-capil-
lary venules, bacterial invasion proceeds to the tunica media
and obliterates the vessel,5 causing inflammation and throm-
bosis of the post-capillary vessels. Arteries also become
involved, either directly by bacterial invasion or by venous
obliteration, leading to separation of dermis and epidermis
and causing bullae formation.6 Bacterial load of the bullae
increases, producing a central area of necrosis surrounded by
an erythematous halo. In our patient, the lesions eventually
became necrotic.
EG is typically and most commonly caused by P. aerugi-
nosa. However, EG-like lesions have also been observed in
patients with other Gram-negative bacterial (Aeromonas
hydrophila, Klebsiella pneumoniae, Serratia marcescens,
Xanthomonas maltophilia, Morganella morganii, Escherichia
coli, Citrobacter freundii, etc.), fungal (Candida albicans,
Aspergillus fumigatus, Fusarium solani, Scytalidium dimidia-
tum, etc.) and viral (Herpes simplex virus) infections.7—9 To
the best of our knowledge, lesions associated with Gram-
positive bacteria have not been reported in the literature;
therefore, our patient seems to be the first case in which EG-
like lesions are associated with MRSA sepsis.
The clinical scenarios associated with EG-like lesions are
reported as leukemia, immunosuppression, chemotherapy,
urinary tract infection and pneumonia.9 In our patient, the
EG-like lesions were associated with MRSA sepsis due to
complications of the COPD during follow-up in the ICU.
In conclusion, EG-like skin lesions can occur in immuno-
compromised patients undergoing long-term treatment in
the ICU. Despite the fact that they are commonly associated
with pseudomonal sepsis, other bacterial and nonbacterial
causes should be kept in mind for the differential diagnosis,
and management plans should be tailored accordingly.
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